These results could have therapeutic implications, as it has been shown that targeting NAD+ metabolism can sensitize tumor cells to drug and radiation therapy [85, 86], adding another potential rationale for targeting mitochondrial STAT3 during cancer therapy [40]. This evidence concerns the gene STAT3 and neoplasm.